Antioxidant Enzyme System Completed Phase 3 Trials for Magnesium oxide (DB01377)

IndicationStatusPhase
DBCOND0093006 (Antioxidant Enzyme System)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03341117Acetylsalicylic Acid and Type 2 Diabetes MellitusTreatment